Merus Competitors and Similar CompaniesClear all
Merus's competitors and similar companies include ANI Pharmaceuticals, Olainfarm, Biosearch Life and Aerie Pharmaceuticals.
 Merus Merus is a clinical-stage immuno-oncology company developing innovative bispecific antibody therapeutics with the goal of treating and potentially curing cancer patients. |  ANI Pharmaceuticals ANI Pharmaceuticals develops, manufactures and markets top quality prescription pharmaceuticals, made in the U.S.A. |  Olainfarm Olainfarm manufactures and distributes chemical and pharmaceutical products primarily in Latvia. |  Biosearch Life Biosearch Life, a biotechnology company, operates in pharmaceutical, nutraceutical, and functional food sectors internationally. |  Aerie Pharmaceuticals Aerie Pharmaceuticals is a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with glaucoma and other diseases of the eye. | |
Founding Date | Founding Date 2003 | Founding Date 1996 | Founding Date 1972 | Founding Date 2000 | Founding Date 2005 |
Type | Type Public | Type Public | Type Public | Type Public | Type Public |
Tags | |||||
Locations | Locations Utrecht, NL HQ Cambridge, US | Locations Baudette, US HQ Oakville, CA Baudette, US | Locations Olaine, LV HQ | Locations Granada, ES HQ Madrid, ES | Locations Irvine, US HQ Dublin, IE 千代田区, JP Henley On Thames, GB Bedminster, US Durham, US |
Employees | Employees 172 | Employees 33813% increase | Employees 2,191 | Employees 140 | Employees 3808% increase |
Valuation ($) | Valuation ($) 3.6 b | Valuation ($) 1.2 b | Valuation ($) 150.2 m | Valuation ($) 149.2 m | Valuation ($) 722.2 m |
Financial | |||||
Revenue (est.) | Revenue (est.) $43.9m (FY, 2023) | Revenue (est.) $614.4m (FY, 2024) | Revenue (est.) €122.2m (FY, 2020) | Revenue (est.) N/A | Revenue (est.) $194.1m (FY, 2021) |
Cost of goods | Cost of goods N/A | Cost of goods N/A | Cost of goods €44.5m (FY, 2020) | Cost of goods N/A | Cost of goods $26.8m (FY, 2021) |
Gross profit | Gross profit $43.9m (FY, 2023) | Gross profit N/A | Gross profit €80.1m (FY, 2020) | Gross profit N/A | Gross profit N/A |
Net income | Net income ($154.9m) (FY, 2023) | Net income ($18.5m) (FY, 2024) | Net income €9.5m (FY, 2020) | Net income N/A | Net income ($74.8m) (FY, 2021) |
Funding | |||||
Total funding raised | Total funding raised $ 149.3m | Total funding raised N/A | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 388.6m |
For sources of this data, please see the company profile
View Company Profiles
ANI Pharmaceuticals
HQ
Baudette, US
Employees
338↑ 13% increase
ANI Pharmaceuticals develops, manufactures and markets top quality prescription pharmaceuticals, made in the U.S.A.
View companyOlainfarm
HQ
Olaine, LV
Employees
2,191
Olainfarm manufactures and distributes chemical and pharmaceutical products primarily in Latvia.
View companyBiosearch Life
HQ
Granada, ES
Employees
140
Biosearch Life, a biotechnology company, operates in pharmaceutical, nutraceutical, and functional food sectors internationally.
View companyAerie Pharmaceuticals
HQ
Irvine, US
Employees
380↑ 8% increase
Aerie Pharmaceuticals is a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with glaucoma and other diseases of the eye.
View company